Labshake search
Citations for Tocris :
101 - 150 of 846 citations for 7 Octen 1 ol since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2022Quote: To observe chromosome alignment in fixed-cell experiments – with the advantage of taking high resolution images and easily selecting many cells for further analysis - cells were released from thymidine block for 7 hours before being treated for 2 hours with RO-3306 (10μM, Tocris) – to synchronise cells at the G2/M boundary - or with a 3-hour treatment with STLC (10μM ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Cell Biology 2019Quote: ... HeLa FRT cells were released from thymidine block (40 h after siRNA treatment) for 7 hours before arresting at the G2/M boundary with RO-3306 treatment (10μM, Tocris) for 2 hours ...
-
bioRxiv - Neuroscience 2023Quote: ... slices were incubated in recording ACSF supplemented with 5 μM 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris, 1045) and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Neuroscience 2021Quote: Structural plasticity of dendritic spines was stimulated through uncaging of 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate, Tocris) using a Ti ...
-
bioRxiv - Cell Biology 2020Quote: The following soluble reagents were used to treat DCs in motility assays and for samples analyzed by western blotting: w-7 hydrochloride (Tocris), sto-609 acetate (Tocris) ...
-
bioRxiv - Neuroscience 2021Quote: ... 10 μM NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline) and 50 μM AP-5 (Tocris Bioscience, UK) were applied in the bath to block excitatory synaptic responses.
-
bioRxiv - Microbiology 2022Quote: ... 3 μl of 10 mM of NBD-(linezolid-7-nitrobenz-2-oxa-1,3-diazol-4-yl)-amino-D-alanine (NADA) (Tocris Bioscience) was added to the resuspension ...
-
bioRxiv - Neuroscience 2023Quote: ... was set to 720 nm and used to uncage 4-Methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-caged glutamate, Tocris). Up to four spines in separate regions of interest (ROI ...
-
bioRxiv - Neuroscience 2023Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5) and 7-(Hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester (CPCCOEt) were purchased from Tocris Bioscience or from HelloBio (UK) ...
-
bioRxiv - Neuroscience 2022Quote: ... containing 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 50 μM D,L-2-amino-5-phosphonovaleric acid (AP5) (both from Tocris, Bristol, UK) to block recurrent glutamatergic signaling.
-
bioRxiv - Neuroscience 2023Quote: ... 12-well plates at 7-8 x 105 cells/well in mTeSR1 with 10 µM rho-kinase inhibitor (Y- 27632; Tocris, 1254). The following day ...
-
bioRxiv - Neuroscience 2023Quote: ... Media were changed on days 9 and 11 with N2B27 with the same supplements as day 7 but with the addition of DAPT (10 mM; Tocris, 2634/10). At day 14 ...
-
bioRxiv - Neuroscience 2024Quote: ... a guide cannula (-0.94 AP, -2.85 ML) was implanted 7 days before administration of 0.2 μL KA (0222; Tocris, Minneapolis, MN; 1.5 mg/mL; -3.75 DV) in PBS ...
-
bioRxiv - Molecular Biology 2021Quote: ... 1 µM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2023Quote: ... 1 μM DMH-1 (Tocris) and 3 μM CHIR99021 (Tocris) ...
-
bioRxiv - Developmental Biology 2021Quote: ... and 1 μM IDE-1 and 1 μM XAV939 (both Tocris). 48 hours after the onset of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 μM endo-IWR-1 (Tocris), and 10 μM SB431542 (Stemgent).
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) on 6-well ECM collagen-I-coated peptide plates (Corning ...
-
bioRxiv - Developmental Biology 2023Quote: ... and 1 μM DMH-1 (Tocris) and mixed with 90 μl Growth Factor Reduced Matrigel (Corning) ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Developmental Biology 2021Quote: ... supplemented with 1 μM IDE-1 (Tocris), 0.2% (v/v ...
-
bioRxiv - Cancer Biology 2021Quote: ... Torin1 (1 μM, Tocris, 10-1-4247), and AICAR (2 mM ...
-
bioRxiv - Developmental Biology 2022Quote: ... and endothelin 1 (ET-1) from Tocris Bioscience (Bristol ...
-
bioRxiv - Genomics 2021Quote: ... and 1 μM tetrodotoxin (TTX; Tocris #1078/1). KCl (55mM ...
-
bioRxiv - Cell Biology 2022Quote: ... MLSA1 (Tocris, 4746, incubation 1 μM for 1 h). For all experiments in microfluidic chips involving drugs ...
-
bioRxiv - Neuroscience 2020Quote: ... rabbit anti-GLT-1 (Tocris, #2063, dilution 1:2000). Secondary antibodies against mouse ...
-
bioRxiv - Biophysics 2022Quote: ... 50 μL well-1 of 2X neurotensin 1-13 (Tocris) solutions were added to the appropriate well and incubated for an additional 30 min ...
-
bioRxiv - Neuroscience 2022Quote: ... 1 DAMGO (Tocris), 10 Bombesin (Tocris) ...
-
bioRxiv - Cell Biology 2019Quote: ... ITD-1 (Tocris) compound was administrated at 5mM.
-
bioRxiv - Developmental Biology 2021Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Neuroscience 2019Quote: ... and 1% P/S) supplemented with 1 µM purmorphamine (Tocris Bioscience), a SHH agonist ...
-
bioRxiv - Cancer Biology 2022Quote: ... the BMP type-I receptor inhibitor DMH-1 (1 μM, Tocris) and ROCK inhibitor Y-27632 2HCl (10 μM) ...
-
bioRxiv - Cell Biology 2021Quote: ... and 6-O-[(4,5-Dimethoxy-2-nitrophenyl)methyl]-2,3-O-(1-methylethylidene)-D-myo-Inositol 1,4,5-tris[bis[(1-oxopropoxy)methyl]phosphate] (ci-IP3/PM; 1 μM, Tocris #6210) in imaging buffer with 0.01 % BSA in dark at room temperature ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with FGF-2 (20 ng ml−1), Activin-A (50 ng ml−1), BMP-4 (10 ng ml−1, R&D) and LY294002 (10 mM Tocris). Media was changed again after 42 hours to CDM-BSA supplemented with FGF-2 (8 ng ml−1) ...
-
bioRxiv - Immunology 2019Quote: ... 1 uM capsaicin (Tocris) and 40 mM KCl (Sigma ...
-
bioRxiv - Neuroscience 2020Quote: ... dAP5 (1 mM, Tocris) was topically applied to the dura mater ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 μM dexamethasone (Tocris) and 10 nM LONG R3 IGF-1 (IGF ...
-
bioRxiv - Neuroscience 2020Quote: ... MPEP (1 μM, Tocris), NBQX (10 μM ...
-
bioRxiv - Neuroscience 2020Quote: ... 1 μM oxytocin (Tocris) in ACSF was washed on for 10-15 minutes ...
-
bioRxiv - Neuroscience 2020Quote: ... MRS2500 (1 µM, Tocris) was applied by addition to superfused ACSF.
-
bioRxiv - Developmental Biology 2022Quote: ... FIIN-1 (20nM, Tocris), Fgfr2iiib-Fc (1µg/ml ...
-
bioRxiv - Biochemistry 2022Quote: ... SL-0101-1 (Tocris), palbociclib (Sigma) ...
-
bioRxiv - Neuroscience 2022Quote: ... TTX (1 µM, Tocris), 4-AP (0.1-0.3 mM ...
-
bioRxiv - Neuroscience 2020Quote: ... Y27632 (1 µM, Tocris), GDNF (10 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... necrostatin-1 (Tocris Bioscience), cycloheximide (Sigma) ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 μM dexamethasone (Tocris) and 10 nM LONG R3 IGF-1 (IGF ...